BIO Asia–Taiwan 2023 亞洲生技大會

BIO Asia–Taiwan 2023 亞洲生技大會


Aparajeeta Priyadarasini

Session 10 – AI & Digital Health

Date:28 July (Thursday)
Time:  15:40 – 17:10 (GMT+8)

Aparajeeta Priyadarasini

Manager, Solution Consulting
​Medidata, a Dassault Systèmes company 

Aparajeeta Priyadarasini has over 15 years of experience in healthcare and life sciences industry. She has held various roles in global pharmaceutical companies and contract research organization, covering clinical research, biotechnology, medical device.

She was responsible for clinical operation of different study phases for Sanofi Aventis, Asia-Pacific Regional HQ prior to Medidata. In her current role, Aparajeeta provides consulting to the pharmaceutical, biotech and CRO companies on clinical operations process and technologies.


Speech title & Synopsis

Managing Trial Planning and Design with Artificial Intelligence

Artificial Intelligence (AI) will play a major role in transforming clinical trial processes and keeping us healthier and better protected from diseases. The recent pandemic has forced the industry to re-look at the dynamic nature of clinical trial landscape. This resulted in a need for study teams to design a lean yet thorough protocol that answers the research questions without the need to collect additional data.

In this session we will discuss AI offerings of Medidata to optimize trial design, planning, site selection and enrollment decisions and live insights that are critical for successful trial planning and implementation.